Last updated September 4, 2026
EDX Medical Group plc has 431,373,146 ordinary shares of £0.01 each in issue. Click here for the latest share price.
Securities not in public hands: 37.59%
Significant Shareholders
| Name | Percentage of issued share capital | |
|---|---|---|
| Professor Sir Christopher Evans OBE | 136,161,523 | 31.58% |
| Bridgemere Securities Ltd | 38,970,000 | 9.03% |
| West Coast Capital Holdings Limited | 31,439,582 | 7.29% |
| Countywide Development Limited | 27,339,047 | 5.60% |
| Dr Michael Hudson | 20,650,000 | 4.79% |
| Securities Services Nominees Limited | 3.31% |
The Company has entered into an unsecured convertible loan note (CLN) agreement for up to £2 million with the Company’s founder, Professor Sir Christopher Evans. The agreement has a duration of 48 months and, in the event of conversion, equity in the Company will be issued to Sir Christopher Evans at a price equal to the higher of i) 14p per share; or ii) a price per EDX Medical Group Plc share equal to the price paid for shares issued for subscription in a minimum amount of £1 million within the terms of the CLN.
Restrictions on Share Transfer
There are no restrictions on the transferability of the shares.
Exchanges / Trading Platforms
The Company’s shares are listed on the AIM Market of the London Stock Exchange.
Takeover Regulations
The Company is subject to the UK City Code on Takeovers and Mergers.
